Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin (TERAS)

This study has been completed.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: September 29, 2009
Last updated: June 12, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)